Third Harmonic Bio Management
Management criteria checks 2/4
Third Harmonic Bio's CEO is Natalie Holles, appointed in Aug 2021, has a tenure of 2.75 years. total yearly compensation is $2.54M, comprised of 23.9% salary and 76.1% bonuses, including company stock and options. directly owns 2.98% of the company’s shares, worth $17.05M. The average tenure of the management team and the board of directors is 0.3 years and 2.8 years respectively.
Key information
Natalie Holles
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 23.9% |
| CEO tenure | 2.8yrs |
| CEO ownership | 3.0% |
| Management average tenure | less than a year |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Here's Why We're Not At All Concerned With Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation
Apr 06
We're Hopeful That Third Harmonic Bio (NASDAQ:THRD) Will Use Its Cash Wisely
Sep 06We're Hopeful That Third Harmonic Bio (NASDAQ:THRD) Will Use Its Cash Wisely
May 02We're Not Very Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Rate
Dec 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$30m |
| Dec 31 2023 | US$3m | US$608k | -US$31m |
| Sep 30 2023 | n/a | n/a | -US$35m |
| Jun 30 2023 | n/a | n/a | -US$36m |
| Mar 31 2023 | n/a | n/a | -US$36m |
| Dec 31 2022 | US$10m | US$530k | -US$35m |
| Sep 30 2022 | n/a | n/a | -US$39m |
| Jun 30 2022 | n/a | n/a | -US$39m |
| Mar 31 2022 | n/a | n/a | -US$34m |
| Dec 31 2021 | US$2m | US$197k | -US$30m |
Compensation vs Market: Natalie's total compensation ($USD2.54M) is about average for companies of similar size in the US market ($USD2.49M).
Compensation vs Earnings: Natalie's compensation has been consistent with company performance over the past year.
CEO
Natalie Holles (50 yo)
2.8yrs
Tenure
US$2,541,873
Compensation
Ms. Natalie C. Holles serves as Chief Executive Officer since August 9, 2021 and Director of Third Harmonic Bio, Inc. since August 2021. She was an Independent Director at Allakos Inc. since December 2020...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.8yrs | US$2.54m | 2.98% $ 17.1m | |
| Chief Administrative Officer | 1.9yrs | US$1.11m | 0% $ 0 | |
| Chief Medical Officer | 1.9yrs | US$1.38m | 0% $ 0 | |
| Chief Financial & Business Officer | less than a year | no data | no data | |
| Chief Scientific Officer | no data | no data | no data | |
| Senior Vice President of Development Operations | no data | no data | no data | |
| Chief Non-Clinical Development Officer | no data | no data | no data | |
| Chief Development Operations Officer | no data | no data | no data | |
| Treasurer & Secretary | no data | no data | no data |
0.3yrs
Average Tenure
50yo
Average Age
Experienced Management: THRD's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.8yrs | US$2.54m | 2.98% $ 17.1m | |
| Independent Director | 1.8yrs | US$172.85k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$62.71k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$119.84k | 0% $ 0 | |
| Independent Chairman | 4yrs | US$174.62k | 0.31% $ 1.8m | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 5.1yrs | US$119.84k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$130.04k | 0.21% $ 1.2m | |
| Non-Employee Supervisor | less than a year | no data | no data |
2.8yrs
Average Tenure
54.5yo
Average Age
Experienced Board: THRD's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.